Abstract: SAMe and its physiologically tolerated salts are administered to a patient for the treatment of reperfusion damage caused by temporary focal ischemia.
Abstract: A process with whose aid active substances of low solubility can be processed together with phospholipids to give a homogeneous solution, which comprisesa) mixing the active substance with a phospholipid,b) adding an acidic aqueous solution of a carbohydrate to the residue at elevated temperature, and stirring this mixture at elevated temperature until a homogeneous colloidal solution is produced, andc) cooling the solution, and adjusting to a pH of 4-5 and sterilizing is described.
© 2024 Justia
